O

Oblita Therapeutics

Active companySociété à responsabilité limitéeBE 0832.102.424
Registered officeZoersel
Founded2010
Headcount
Locations1 establishments
O
Product universe
72.101 · Recherche-développement en biotechnologie

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Identity, activity, filings and a two-year financial snapshot — like the public profile.

Company summary

Not provided

Gross margin 2024
-15.2 k€
+32 % year on year
Net result 2024
-68.7 k€
Positive result
Headcount
Microstructure
Establishments
1
1 municipalities

Activities and NACE codes

Every code, not only the principal activity.
All NACE codes
Recherche-développement en biotechnologie (72101)Recherche-développement en autres sciences physiques et naturelles (72109)Fabrication d’autres produits alimentaires nca (10890)Études de marché et sondages (73200)Fabrication de médicaments (21201)Commerce de gros de produits pharmaceutiques et médicaux (46460)Commerce de détail d'articles de droguerie et de produits d'entretien (47783)Commerce de gros d'autres produits alimentaires nca (46389)Activités d’agence de publicité (73110)Autres activités de service de soutien aux entreprises nca (82990)Fabrication de produits pharmaceutiques de base (21100)Activités de société holding (64210)Fabrication d’aliments homogénéisés et diététiques (10860)Organisation de salons professionnels et congrès (82300)Commerce de gros de produits d'entretien (46442)Activités des sociétés holding (64200)Recherche-développement en autres sciences physiques et naturelles (72190)Commerce de détail d'articles de droguerie et de produits d'entretien en magasin spécialisé (47784)

Legal publications

Official sources, with a link to the detail.

Map and locations

Registered office and establishments.

Establishment list

HQ · ZoerselOostmallebaan 87 2980 Zoersel · 2011-01-01
HQ Sites 1 · 1 municipalities

Source BCE / KBO

Financial analysis

Ratios, structures, last two years and commentary.
Financial year 2024
Total assets502.2 k€+12 %
Equity145.9 k€-32 %
Liabilities356.3 k€+52 %
Cash16.7 k€-78 %
Solvency29 %-40 %
Liquidity0.08-76 %
ROE-47 %-327 %
Customer payment term-148 d

Last two years

20242023Trend
Gross margin-15.2 k€-22.5 k€+32 %
Net result-68.7 k€-24.6 k€-179 %
Total assets502.2 k€449.0 k€+12 %
Equity145.9 k€214.6 k€-32 %

Team and key contacts

Contacts extracted from the annual accounts.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Products, what the company does, opportunities, events and key people.

What the company does

Offers, origin and prospecting angles.
Purpose

Not provided

Origin

Not provided

Founders

Not provided

Flagship offers

Not provided

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Visuals

Logo, products and brand world.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Team and key contacts

Contacts extracted from the annual accounts.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Headcount, workplaces, social balance and people you would meet.

Candidate reading

What a candidate can already see before applying.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Workplaces

Registered office and establishments.

Establishment list

HQ · ZoerselOostmallebaan 87 2980 Zoersel · 2011-01-01
HQ Sites 1 · 1 municipalities

Source BCE / KBO

Team and key contacts

Contacts extracted from the annual accounts.

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view

Structure, ratios and multi-year analysis.

Financial analysis

Ratios, structures, last two years and commentary.
Financial year 2024
Total assets502.2 k€+12 %
Equity145.9 k€-32 %
Liabilities356.3 k€+52 %
Cash16.7 k€-78 %
Solvency29 %-40 %
Liquidity0.08-76 %
ROE-47 %-327 %
Customer payment term-148 d

Last two years

20242023Trend
Gross margin-15.2 k€-22.5 k€+32 %
Net result-68.7 k€-24.6 k€-179 %
Total assets502.2 k€449.0 k€+12 %
Equity145.9 k€214.6 k€-32 %

Financial analysis

Contacts, website, LinkedIn, visuals

Full profile available
Digital identity, team, product visuals and detailed analysis are in the complete view.

Request the full view